Paeoniflorin Ameliorates Hyperprolactinemia-Induced Inhibition of Osteoblastogenesis by Suppressing the NF-κB Signaling Pathway

por Sun, Xiaohong, Zhu, Keda, Feng, Chengcheng, Zhu, Jie, Chen, Shuangshuang, Tang, Wenkai, Wang, Zhifang, Xiao, Long, Li, Hong, Geng, Dechun, Wang, Zhirong
Publicado 2022

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways

por Xiao, Long, Zhong, Mengdan, Huang, Yu, Zhu, Jie, Tang, Wenkai, Li, Danyong, Shi, Jiandong, Lu, Aiqing, Yang, Huilin, Geng, Dechun, Li, Hong, Wang, Zhirong
Publicado 2020

Puerarin inhibits titanium particle‐induced osteolysis and RANKL‐induced osteoclastogenesis via suppression of the NF‐κB signaling pathway

por Tang, Wenkai, Xiao, Long, Ge, Gaoran, Zhong, Mengdan, Zhu, Jie, Qin, Jialin, Feng, Chencheng, Zhang, Wenhao, Bai, Jiaxiang, Zhu, Xuesong, Wei, Minggang, Geng, Dechun, Wang, Zhirong
Publicado 2020

Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway

por Zhu, Jie, Feng, Chengcheng, Zhang, Weicheng, Wang, Zhidong, Zhong, Mengdan, Tang, Wenkai, Wang, Zhifang, Shi, Haiwei, Yin, Zhengyu, Shi, Jiandong, Huang, Yu, Xiao, Long, Geng, Dechun, Wang, Zhirong
Publicado 2022